• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过全因子设计优化5-氟尿嘧啶的低密度脂蛋白靶向纳米结构脂质载体

Optimization of LDL targeted nanostructured lipid carriers of 5-FU by a full factorial design.

作者信息

Andalib Sare, Varshosaz Jaleh, Hassanzadeh Farshid, Sadeghi Hojjat

机构信息

Department of Pharmaceutics, Faculty of Pharmacy and Novel Drug Delivery Systems Research Center, Isfahan University of Medical Sciences, Isfahan, India.

出版信息

Adv Biomed Res. 2012;1:45. doi: 10.4103/2277-9175.100147. Epub 2012 Aug 28.

DOI:10.4103/2277-9175.100147
PMID:23326776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3544134/
Abstract

BACKGROUND

Nanostructured lipid carriers (NLC) are a mixture of solid and liquid lipids or oils as colloidal carrier systems that lead to an imperfect matrix structure with high ability for loading water soluble drugs. The aim of this study was to find the best proportion of liquid and solid lipids of different types for optimization of the production of LDL targeted NLCs used in carrying 5-Fu by the emulsification-solvent evaporation method.

MATERIALS AND METHODS

The influence of the lipid type, cholesterol or cholesteryl stearate for targeting LDL receptors, oil type (oleic acid or octanol), lipid and oil% on particle size, surface charge, drug loading efficiency, and drug released percent from the NLCs were studied by a full factorial design.

RESULTS

The NLCs prepared by 54.5% cholesterol and 25% of oleic acid, showed optimum results with particle size of 105.8 nm, relatively high zeta potential of -25 mV, drug loading efficiency of 38% and release efficiency of about 40%. Scanning electron microscopy of nanoparticles confirmed the results of dynamic light scattering method used in measuring the particle size of NLCs.

CONCLUSIONS

The optimization method by a full factorial statistical design is a useful optimization method for production of nanostructured lipid carriers.

摘要

背景

纳米结构脂质载体(NLC)是固体和液体脂质或油的混合物,作为胶体载体系统,可形成具有高水溶性药物负载能力的不完美基质结构。本研究的目的是通过乳化 - 溶剂蒸发法,找出不同类型的液体和固体脂质的最佳比例,以优化用于运载5-氟尿嘧啶的低密度脂蛋白靶向NLC的生产。

材料与方法

通过全因子设计研究脂质类型(胆固醇或硬脂酸胆固醇酯用于靶向低密度脂蛋白受体)、油类型(油酸或辛醇)、脂质和油的百分比对粒径、表面电荷、药物负载效率以及NLC中药物释放百分比的影响。

结果

由54.5%胆固醇和25%油酸制备的NLC显示出最佳结果,粒径为105.8 nm,相对较高的ζ电位为 -25 mV,药物负载效率为38%,释放效率约为40%。纳米颗粒的扫描电子显微镜证实了用于测量NLC粒径的动态光散射法的结果。

结论

全因子统计设计的优化方法是生产纳米结构脂质载体的一种有用的优化方法。

相似文献

1
Optimization of LDL targeted nanostructured lipid carriers of 5-FU by a full factorial design.通过全因子设计优化5-氟尿嘧啶的低密度脂蛋白靶向纳米结构脂质载体
Adv Biomed Res. 2012;1:45. doi: 10.4103/2277-9175.100147. Epub 2012 Aug 28.
2
Synthesis of octadecylamine-retinoic acid conjugate for enhanced cytotoxic effects of 5-FU using LDL targeted nanostructured lipid carriers.合成十八烷基胺-视黄酸缀合物,利用 LDL 靶向的纳米结构脂质载体增强 5-FU 的细胞毒性作用。
Eur J Med Chem. 2012 Aug;54:429-38. doi: 10.1016/j.ejmech.2012.05.024. Epub 2012 May 28.
3
Eudragit S-100 Surface Engineered Nanostructured Lipid Carriers for Colon Targeting of 5-Fluorouracil: Optimization and In Vitro and In Vivo Characterization.用于5-氟尿嘧啶结肠靶向的Eudragit S-100表面工程化纳米结构脂质载体:优化及体外和体内表征
AAPS PharmSciTech. 2021 Aug 12;22(6):216. doi: 10.1208/s12249-021-02099-3.
4
Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.半乳糖化的纳米结构脂质载体用于向肝癌递送 5-FU。
J Liposome Res. 2012 Sep;22(3):224-36. doi: 10.3109/08982104.2012.662653. Epub 2012 Mar 5.
5
Design and Optimization of Febuxostat-loaded Nano Lipid Carriers Using Full Factorial Design.使用全因子设计法对非布司他负载纳米脂质载体进行设计与优化
Turk J Pharm Sci. 2021 Feb 25;18(1):61-67. doi: 10.4274/tjps.galenos.2019.32656.
6
Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast.用于阿普斯特局部给药的纳米结构脂质载体的配方、优化及体外评价
Dermatol Ther. 2020 May;33(3):e13370. doi: 10.1111/dth.13370. Epub 2020 Apr 15.
7
Effect of the Surfactant and Liquid Lipid Type in the Physico-chemical Characteristics of Beeswax-based Nanostructured Lipid Carrier (NLC) of Metformin.表面活性剂和液态脂质类型对基于蜂蜡的二甲双胍纳米结构脂质载体(NLC)物理化学特性的影响。
Pharm Nanotechnol. 2021;9(3):200-209. doi: 10.2174/2211738509666210222143716.
8
Antimicrobial Activity of Nanostructured Lipid Carriers Loaded Seed Oil against .纳米结构化脂质载体负载 种子油的抗菌活性研究
Pharm Nanotechnol. 2020;8(6):485-494. doi: 10.2174/2211738508999201105142945.
9
Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil).载药纳米结构脂质载体(NLCs):液体脂质(油)的作用。
Curr Drug Deliv. 2021;18(3):249-270. doi: 10.2174/1567201817666200423083807.
10
Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.第二代脂质纳米粒(NLC)作为盐酸乐卡地平的口服药物载体。
Colloids Surf B Biointerfaces. 2014 Apr 1;116:81-7. doi: 10.1016/j.colsurfb.2013.12.012. Epub 2013 Dec 30.

引用本文的文献

1
Enhanced antitumor efficacy of nanostructured lipid carrier co-loaded with docetaxel and 5-fluorouracil for targeted gastric cancer therapy.纳米结构脂质载体共载多西他赛和5-氟尿嘧啶用于靶向胃癌治疗的抗肿瘤疗效增强
Med Oncol. 2025 Jan 22;42(2):53. doi: 10.1007/s12032-025-02603-w.
2
Nanostructured lipid carriers loaded with morellic acid for enhanced anticancer efficacy: preparation, characterization, pharmacokinetics and anticancer evaluation.负载羊肚菌酸的纳米结构脂质载体用于增强抗癌疗效:制备、表征、药代动力学及抗癌评价
Am J Cancer Res. 2024 Mar 15;14(3):1101-1120. doi: 10.62347/VBOX7111. eCollection 2024.
3
Pentapeptide cRGDfK-Surface Engineered Nanostructured Lipid Carriers as an Efficient Tool for Targeted Delivery of Tyrosine Kinase Inhibitor for Battling Hepatocellular Carcinoma.

本文引用的文献

1
Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer.5-氟尿嘧啶固体脂质纳米粒的优化:治疗结肠癌的初步研究。
Int J Med Sci. 2010 Nov 22;7(6):398-408. doi: 10.7150/ijms.7.398.
2
Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement.将液态脂质纳入脂质纳米粒以增强眼部药物传递。
Nanotechnology. 2010 Jan 15;21(2):025101. doi: 10.1088/0957-4484/21/2/025101. Epub 2009 Dec 3.
3
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
五肽 cRGDfK-表面工程纳米结构化脂质载体作为靶向递送酪氨酸激酶抑制剂用于治疗肝细胞癌的有效工具。
Int J Nanomedicine. 2023 Nov 28;18:7021-7046. doi: 10.2147/IJN.S438307. eCollection 2023.
4
Cannabidiol-Loaded Nanostructured Lipid Carriers (NLCs) for Dermal Delivery: Enhancement of Photostability, Cell Viability, and Anti-Inflammatory Activity.用于皮肤给药的载大麻二酚纳米结构脂质载体(NLCs):光稳定性、细胞活力和抗炎活性的增强
Pharmaceutics. 2023 Feb 6;15(2):537. doi: 10.3390/pharmaceutics15020537.
5
The protective impact of adapted trimebutine maleate-loaded nanostructured lipid carriers for alleviating the severity of acute colitis.马来酸曲美布汀载药纳米脂质载体的改良对缓解急性结肠炎严重程度的保护作用。
Drug Deliv. 2022 Dec;29(1):906-924. doi: 10.1080/10717544.2022.2050847.
6
Eudragit S-100 Surface Engineered Nanostructured Lipid Carriers for Colon Targeting of 5-Fluorouracil: Optimization and In Vitro and In Vivo Characterization.用于5-氟尿嘧啶结肠靶向的Eudragit S-100表面工程化纳米结构脂质载体:优化及体外和体内表征
AAPS PharmSciTech. 2021 Aug 12;22(6):216. doi: 10.1208/s12249-021-02099-3.
7
Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition.载脂蛋白与脂质体的串扰作为将 5-氟尿嘧啶靶向递送至肝细胞的范例:细胞毒性和肝脏沉积。
Bioengineered. 2021 Dec;12(1):914-926. doi: 10.1080/21655979.2021.1896202.
8
Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cells.将抗癌双靶点热休克蛋白27(HSP27)和人表皮生长因子受体2(HER2)抑制剂设计并封装到低密度脂蛋白中以靶向卵巢癌细胞。
Saudi Pharm J. 2020 Apr;28(4):387-396. doi: 10.1016/j.jsps.2020.01.020. Epub 2020 Feb 3.
9
Freeze-Dried Lopinavir-Loaded Nanostructured Lipid Carriers for Enhanced Cellular Uptake and Bioavailability: Statistical Optimization, in Vitro and in Vivo Evaluations.用于增强细胞摄取和生物利用度的冻干洛匹那韦纳米结构脂质载体:统计优化、体外和体内评价
Pharmaceutics. 2019 Feb 25;11(2):97. doi: 10.3390/pharmaceutics11020097.
10
Characterization and toxicity of citral incorporated with nanostructured lipid carrier.柠檬醛与纳米结构脂质载体结合物的表征及毒性
PeerJ. 2018 Jan 4;6:e3916. doi: 10.7717/peerj.3916. eCollection 2018.
用于化妆品和药品皮肤产品中的脂质纳米颗粒(固体脂质纳米粒、纳米结构脂质载体)
Int J Pharm. 2009 Jan 21;366(1-2):170-84. doi: 10.1016/j.ijpharm.2008.10.003. Epub 2008 Oct 17.
4
Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers.固体脂质纳米粒和纳米结构脂质载体——新一代的创新型固体脂质载体
Curr Drug Deliv. 2008 Oct;5(4):324-31. doi: 10.2174/156720108785915087.
5
Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.负载5-氟尿嘧啶纳米颗粒的药代动力学特征及抗癌作用
BMC Cancer. 2008 Apr 15;8:103. doi: 10.1186/1471-2407-8-103.
6
Influence of anatomical site and topical formulation on skin penetration of sunscreens.防晒产品的经皮渗透:解剖部位和局部配方的影响。
Ther Clin Risk Manag. 2005 Sep;1(3):209-18.
7
Photoprotection.光防护
Indian J Dermatol Venereol Leprol. 2007 Mar-Apr;73(2):73-9. doi: 10.4103/0378-6323.31889.
8
Preparation and characterization of oxybenzone-loaded gelatin microspheres for enhancement of sunscreening efficacy.用于增强防晒功效的氧苯酮负载明胶微球的制备与表征
Drug Deliv. 2006 Sep-Oct;13(5):323-30. doi: 10.1080/10717540500398175.
9
Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.水体系中溶剂扩散法制备硬脂酸纳米结构脂质载体及其表征
Colloids Surf B Biointerfaces. 2005 Nov 10;45(3-4):167-73. doi: 10.1016/j.colsurfb.2005.08.005. Epub 2005 Sep 27.
10
The pathophysiology, clinical presentation, and diagnosis of colon cancer and adenomatous polyps.结肠癌和腺瘤性息肉的病理生理学、临床表现及诊断
Med Clin North Am. 2005 Jan;89(1):1-42, vii. doi: 10.1016/j.mcna.2004.08.011.